153 related articles for article (PubMed ID: 7230587)
1. [Adjuvant activity and adjuvant arthritis].
Tanaka A
Kekkaku; 1980 Oct; 55(10):465-7. PubMed ID: 7230587
[No Abstract] [Full Text] [Related]
2. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats.
Kohashi O; Pearson CM; Tamaoki N; Tanaka A; Shimamura K; Ozawa A; Kotani S; Saito M; Hioki K
Infect Immun; 1981 Feb; 31(2):758-66. PubMed ID: 7012019
[TBL] [Abstract][Full Text] [Related]
3. Further study on relationship of anti-tuberculous protection to lung granulomata produced by intravenous injections of synthetic 6-0-mycoloyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine with or without specific antigens.
Yamamoto K; Kato K; Kakinuma M; Okuyama H; Azuma I
Immunology; 1982 Jun; 46(2):473-9. PubMed ID: 7044961
[TBL] [Abstract][Full Text] [Related]
4. [Immunoadjuvant activities of bacterial cell wall components--with special reference to the effects of administration with various vehicles].
Kinoshita F
Osaka Daigaku Shigaku Zasshi; 1978 Jun; 23(1):141-57. PubMed ID: 397324
[No Abstract] [Full Text] [Related]
5. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
[No Abstract] [Full Text] [Related]
6. New model of a synthetic adjuvant, N-acetylmuramyl-L-alanyl-D-isoglutamine- induced arthritis: clinical and histologic studies in athymic nude and euthymic rats.
Kohashi O; Aihara K; Ozawa A; Kotani S; Azuma I
Lab Invest; 1982 Jul; 47(1):27-36. PubMed ID: 7087395
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y
Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
Tsujimoto M
J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
[No Abstract] [Full Text] [Related]
9. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Okumura H; Saiki I; Tanio Y; Kiso M; Hasegawa A; Yamamura Y
Infect Immun; 1981 Jun; 32(3):1305-8. PubMed ID: 7251169
[TBL] [Abstract][Full Text] [Related]
11. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
12. [Epithelioid cell granuloma (author's transl)].
Okabe M; Okuyama H; Morikawa K
Kekkaku; 1980 Oct; 55(10):435-42. PubMed ID: 7014971
[No Abstract] [Full Text] [Related]
13. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.
Chang YH; Pearson CM; Chedid L
J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989
[TBL] [Abstract][Full Text] [Related]
14. [Biological properties of synthetic glycopeptides stimulating immunogenesis and nonspecific resistance].
Dzheksenbaev OSh
Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):13-8. PubMed ID: 7032159
[No Abstract] [Full Text] [Related]
15. Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.
Kohashi O; Kotani S; Shiba T; Ozawa A
Infect Immun; 1979 Nov; 26(2):690-7. PubMed ID: 546792
[TBL] [Abstract][Full Text] [Related]
16. Epithelioid granuloma induced by muramyl dipeptide in immunologically deficient rats.
Nagao S; Ota F; Emori K; Inoue K; Tanaka A
Infect Immun; 1981 Dec; 34(3):993-9. PubMed ID: 6977492
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
18. A new model of experimental arthritis induced by an aqueous form of synthetic adjuvant in immunodeficient rate (SHR and nude rats).
Kohashi O; Kohashi Y; Kotani S; Osawa A
Ryumachi; 1981; 21 Suppl():149-56. PubMed ID: 7344125
[No Abstract] [Full Text] [Related]
19. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
Leclerc C; Audibert F; Chedid L
Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
[TBL] [Abstract][Full Text] [Related]
20. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
